PharmaVentures
OXFORD, England, October 20, 2011 -
PharmaVentures today announced the launch of PharmaDealsEssential Deal Trends: Oncology 2011.
OXFORD, England, October 4, 2011 -
PharmaVentures today announced the appointment of Andy Smith as Head of Corporate Finance to significantly enhance Pharmaventures' advisory capabilities and offerings to the global healthcare and investment communities.
OXFORD, England, July 12, 2011 -
PharmaVentures Limited, experts in deals and alliances, are
pleased to announce that they have been engaged by Avexa Limited to
seek an out-licensing partner for apricitabine (ATC), a late-stage,
novel treatment for HIV infection.
OXFORD, England, June 7, 2011 -
PharmaVentures today announced the appointment of Ping Shek as Senior
Director in the Transactions division of Corporate Advisory working on a
number of key M&A and divestment mandates in the healthcare business sector.
OXFORD, England, February 22, 2011 - PharmaDeals(R) research has revealed that the early stages of recovery
are now evident within pharmaceutical deal-making activity.
More News
- PharmaVentures Acts as Advisor and Broker to Dr Reddy's to Identify and Secure Product Marketing Opportunities for the Russian/CIS Market
- New Business Development Expert Brings More Than 20 Years of Industry M&A and Licensing Experience to Strengthen Pharmaventures' Corporate Advisory Services to its Clients
- As Pharmaceutical Deal Making Becomes More Competitive, PharmaDeals(R) Resource Expands its Deal Coverage
- PharmaTelevision Launches the First Daily News Show for the Life Sciences Industry
- PharmaTelevision Launches New Premium Content Service
